StockData
FibroBiologics, Inc. logo

FibroBiologics, Inc. (FBLG) income statement

FBLGNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 2/30
$0.70−0.13 (-15.06%)

Close on Nov 20, 2026Market cap $4.69MP/E –Yield –

See a number that looks wrong?